SP794DIFFERENCES IN THE INCIDENCE OF INFECTIONS AND RENAL OUTCOMES BETWEEN T LYMPHOCYTE‐DEPLETING RABBIT‐DERIVED ANTITHYMOCYTE GLOBULIN (rATG) vs IL‐2 RECEPTOR ANTAGONIST (IL2R) AS INDUCTION THERAPY IN KIDNEY DONATION AFTER CONTROLLED CARDIAC DEATH (DCD). (13th June 2019)